HHS lines up nearly $700M in supply deals to combat monkeypox and stock up on a smallpox treatment
The Department of Health and Human Services is doubling down on efforts to secure more doses of Bavarian Nordic’s monkeypox vaccine and Chimerix’s smallpox treatment as the CDC reveals that few people have completed their full vaccine series.
BARDA announced on Monday that it’s shelling out $11 million to Michigan-based Grand River Aseptic Manufacturing, which agreed earlier this month to perform fill and finish services for Bavarian Nordic’s monkeypox vaccine Jynneos.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.